WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018078186) INHALABLE POWDER COMPOSITION COMPRISING IL-13 ANTIBODY
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/078186 International Application No.: PCT/EP2017/077923
Publication Date: 03.05.2018 International Filing Date: 31.10.2017
IPC:
C07K 16/24 (2006.01) ,A61K 39/395 (2006.01) ,A61K 9/16 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18
against material from animals or humans
24
against cytokines, lymphokines or interferons
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
395
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
14
Particulate form, e.g. powders
16
Agglomerates; Granulates; Microbeadlets
Applicants: VECTURA LIMITED[GB/GB]; 1 Prospect West Chippenham Wiltshire SN14 6FH, GB
UCB BIOPHARMA SPRL[BE/BE]; 60, Allée de la Recherche 1070 Brussels, BE
Inventors: MORGAN, Frazer Giles; GB
MAIN, Mark Jonathan; GB
PALFRAMAN, Roger; GB
KIRKE, David; GB
Agent: GWILLIAM, David; GB
JONES, Stephen; GB
COOPER, Simon; GB
PUGH, Eilidh; GB
FERRAR, Nicholas; GB
MACDONALD, Christopher; GB
WRIGHT, Katherine; GB
VAUGHAN, Jennifer; GB
Priority Data:
16196643.731.10.2016EP
Title (EN) INHALABLE POWDER COMPOSITION COMPRISING IL-13 ANTIBODY
(FR) COMPOSITION DE POUDRE INHALABLE COMPRENANT UN ANTICORPS IL -13
Abstract:
(EN) An inhalable powder composition comprises a) an antagonistic antibody which binds human IL-13, b) leucine and c) trehalose. The antibody may comprise a heavy chain, wherein the variable domain of the heavy chain comprises the sequence given in SEQ ID NO:3 and a light chain, wherein the variable domain of the light chain comprises the sequence given in SEQ ID NO:1. Also described is the use of such compositions in the treatment of asthma, as well as inhalers containing such compositions.
(FR) La présente invention concerne une composition de poudre inhalable comprenant : a) un anticorps antagoniste qui se lie à l'IL -13 humaine, b) de la leucine, et c) du tréhalose. L'anticorps peut comprendre une chaîne lourde, le domaine variable de la chaîne lourde comprenant la séquence donnée dans SEQ ID NO : 3 et une chaîne légère, le domaine variable de la chaîne légère comprenant la séquence donnée dans SEQ ID NO : 1. L'invention concerne également l'utilisation de telles compositions dans le traitement de l'asthme, ainsi que des inhalateurs contenant de telles compositions.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)